During the past decade, Oncology Hematology Care Inc-Kenwood conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 64 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 55 clinical trials were completed. i.e. 114.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Hematology Care Inc-Kenwood" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Care Inc-Kenwood" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Care Inc-Kenwood" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Oncology Hematology Care Inc-Kenwood" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Care Inc-Kenwood" are "Drug" (138 trials), "Other" (100 trials), "Biological" (66 trials), "Procedure" (41 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (41 trials), "Carboplatin" (25 trials), "Computed Tomography" (22 trials) and "Biospecimen Collection" (21 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Care Inc-Kenwood" are 137 trials for "All" genders, 21 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Hematology Care Inc-Kenwood". undefined are not yet recruiting, 47 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Oncology Hematology Care Inc-Kenwood, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Care Inc-Kenwood, 6 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".